We have recently reported the presence and a potential proinflammatory role
of IL-18 in the synovium of patients with rheumatoid arthritis, To obtain
direct evidence that IL-18 plays an influential role in articular inflammat
ion, we investigated the development of collagen-induced arthritis in a str
ain of mice lacking IL-18 (IL-18(-/-)) of DBA/1 background. IL-18(-/-) mice
developed markedly reduced incidence of arthritis compared with heterozygo
us or wild-type mice. Of the IL-18(-/-) mice that developed arthritis, the
severity of the disease was significantly reduced compared with the intact
mice, This was accompanied by reduced articular inflammation and destructio
n evident on histology, IL-18(-/-) mice also had significantly reduced Ag-s
pecific proliferation and proinflammatory cytokine (IFN-gamma, TNF-alpha, I
L-6, and IL-12) production by spleen and lymph node cells in response to bo
vine type II collagen (CII) in vitro compared with wild-type mice, parallel
ed in vivo by a significant reduction in serum anti-CII IgG2a Ab level. Tre
atment with rIL-18 completely reversed the disease of the IL-18(-/-) mice t
o that of the wild-type mice, These data directly demonstrate a pivotal rol
e of IL-18 in the development of inflammatory arthritis and suggest that an
tagonists to IL-18 may have therapeutic potential in rheumatic diseases.